{"transactions":[{"id":4614457,"issuer":{"id":4691,"kind":"organization","name":"CONMED Corp","symbol":"CNMD"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true}}],"security":"RSUs (Restricted Stock Units)","published_at":"2026-09-10T19:13:48.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the \"Company\") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-09-08","expiration_date":"2035-09-08","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0000816956-26-000105","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739054/000081695626000105/form4.xml","form_type":"4"}},{"id":4614456,"issuer":{"id":4691,"kind":"organization","name":"CONMED Corp","symbol":"CNMD"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-10T19:13:48.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":500,"source":{"system":"sec-edgar","filing":"0000816956-26-000105","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739054/000081695626000105/form4.xml","form_type":"4"}},{"id":682165,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-19T20:48:33.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":93582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"93,582 restricted stock units vest on 8/17/2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F13","text":"93,582 restricted stock units vest on 8/17/2029."}],"balance_after":93582,"derivative":{"underlying":"Common Stock","underlying_shares":93582},"source":{"system":"sec-edgar","filing":"0000914190-26-000133","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000133/form4.xml","form_type":"4"}},{"id":682164,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-19T20:48:33.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":57590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"19,197 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 19,196 restricted stock units vest on 8/17/2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"19,197 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 19,196 restricted stock units vest on 8/17/2029."}],"balance_after":57590,"derivative":{"underlying":"Common Stock","underlying_shares":57590},"source":{"system":"sec-edgar","filing":"0000914190-26-000133","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000133/form4.xml","form_type":"4"}},{"id":684607,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-18T21:14:42.000Z","date":"2026-08-15","kind":"exercise","planned":false,"acquired":false,"shares":11785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F14","text":"11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028."}],"balance_after":23569,"derivative":{"underlying":"Common Stock","underlying_shares":11785},"source":{"system":"sec-edgar","filing":"0000914190-26-000122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000122/form4.xml","form_type":"4"}},{"id":684606,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-18T21:14:42.000Z","date":"2026-08-15","kind":"exercise","planned":false,"acquired":false,"shares":8543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027."}],"balance_after":8544,"derivative":{"underlying":"Common Stock","underlying_shares":8543},"source":{"system":"sec-edgar","filing":"0000914190-26-000122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000122/form4.xml","form_type":"4"}},{"id":684605,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Options (Right to Buy)","published_at":"2026-08-18T21:14:42.000Z","date":"2026-08-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited."}],"balance_after":1621,"derivative":{"exercise_price":68.54,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":24324},"source":{"system":"sec-edgar","filing":"0000914190-26-000122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000122/form4.xml","form_type":"4"}},{"id":684604,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2026-08-18T21:14:42.000Z","date":"2026-08-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8835},"source":{"system":"sec-edgar","filing":"0000914190-26-000122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000122/form4.xml","form_type":"4"}},{"id":684603,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2026-08-18T21:14:42.000Z","date":"2026-08-15","kind":"exercise","planned":false,"acquired":false,"shares":588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited."}],"balance_after":8835,"derivative":{"underlying":"Common Stock","underlying_shares":588},"source":{"system":"sec-edgar","filing":"0000914190-26-000122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000122/form4.xml","form_type":"4"}},{"id":684602,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Options (Right to Buy)","published_at":"2026-08-18T21:14:42.000Z","date":"2026-08-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited."}],"balance_after":1492,"derivative":{"exercise_price":84.61,"expiration_date":"2030-08-15","underlying":"Common Stock","underlying_shares":22389},"source":{"system":"sec-edgar","filing":"0000914190-26-000122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000122/form4.xml","form_type":"4"}},{"id":684601,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2026-08-18T21:14:42.000Z","date":"2026-08-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8319},"source":{"system":"sec-edgar","filing":"0000914190-26-000122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000122/form4.xml","form_type":"4"}},{"id":684600,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2026-08-18T21:14:42.000Z","date":"2026-08-15","kind":"exercise","planned":false,"acquired":false,"shares":554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited."}],"balance_after":8319,"derivative":{"underlying":"Common Stock","underlying_shares":554},"source":{"system":"sec-edgar","filing":"0000914190-26-000122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000122/form4.xml","form_type":"4"}},{"id":684599,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T21:14:42.000Z","date":"2026-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":10821,"price":72.4,"value":783440.4,"ownership":{"direct":true},"balance_after":82762,"source":{"system":"sec-edgar","filing":"0000914190-26-000122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000122/form4.xml","form_type":"4"}},{"id":684598,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T21:14:42.000Z","date":"2026-08-15","kind":"exercise","planned":false,"acquired":true,"shares":21470,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":93583,"source":{"system":"sec-edgar","filing":"0000914190-26-000122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000122/form4.xml","form_type":"4"}},{"id":701059,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-30T20:11:16.000Z","date":"2026-07-28","kind":"exercise","planned":false,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":47.6,"expiration_date":"2026-08-07","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000914190-26-000106","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000106/form4.xml","form_type":"4"}},{"id":701058,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-30T20:11:16.000Z","date":"2026-07-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":28686,"price":72.07,"value":2067400.02,"ownership":{"direct":true},"balance_after":72113,"source":{"system":"sec-edgar","filing":"0000914190-26-000106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000106/form4.xml","form_type":"4"}},{"id":701057,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-30T20:11:16.000Z","date":"2026-07-28","kind":"exercise","planned":false,"acquired":true,"shares":35000,"price":47.6,"value":1666000.0,"ownership":{"direct":true},"balance_after":100799,"source":{"system":"sec-edgar","filing":"0000914190-26-000106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000106/form4.xml","form_type":"4"}},{"id":753315,"issuer":{"id":4691,"kind":"organization","name":"CONMED Corp","symbol":"CNMD"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true}}],"security":"RSUs (Restricted Stock Units)","published_at":"2026-06-03T20:17:00.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":5772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the \"Company\") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period."}],"balance_after":5772,"derivative":{"exercise_price":0,"exercise_date":"2027-06-01","expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":5772},"source":{"system":"sec-edgar","filing":"0000816956-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816956/000081695626000071/form4.xml","form_type":"4"}},{"id":789128,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T21:22:11.000Z","date":"2026-05-05","kind":"exercise","planned":false,"acquired":false,"shares":26692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully exercisable."}],"balance_after":35000,"derivative":{"exercise_price":47.6,"expiration_date":"2026-08-07","underlying":"Common Stock","underlying_shares":26692},"source":{"system":"sec-edgar","filing":"0000914190-26-000088","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000088/form4.xml","form_type":"4"}},{"id":789127,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-07T21:22:11.000Z","date":"2026-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":23951,"price":56.68,"value":1357542.68,"ownership":{"direct":true},"balance_after":65799,"source":{"system":"sec-edgar","filing":"0000914190-26-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000088/form4.xml","form_type":"4"}},{"id":789126,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-07T21:22:11.000Z","date":"2026-05-05","kind":"exercise","planned":false,"acquired":true,"shares":26692,"price":47.6,"value":1270539.2,"ownership":{"direct":true},"balance_after":89750,"source":{"system":"sec-edgar","filing":"0000914190-26-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000088/form4.xml","form_type":"4"}},{"id":801371,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-24T22:06:19.000Z","date":"2026-04-22","kind":"exercise","planned":false,"acquired":false,"shares":11344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully exercisable."}],"balance_after":61692,"derivative":{"exercise_price":47.6,"expiration_date":"2026-08-07","underlying":"Common Stock","underlying_shares":11344},"source":{"system":"sec-edgar","filing":"0000914190-26-000081","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000081/form4.xml","form_type":"4"}},{"id":801370,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-24T22:06:19.000Z","date":"2026-04-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1363,"price":58.58,"value":79844.54,"ownership":{"direct":true},"balance_after":63058,"source":{"system":"sec-edgar","filing":"0000914190-26-000081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000081/form4.xml","form_type":"4"}},{"id":801369,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-24T22:06:19.000Z","date":"2026-04-22","kind":"exercise","planned":false,"acquired":true,"shares":11344,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":64421,"source":{"system":"sec-edgar","filing":"0000914190-26-000081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000081/form4.xml","form_type":"4"}},{"id":807675,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-16T20:19:36.000Z","date":"2026-04-14","kind":"exercise","planned":false,"acquired":false,"shares":36500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully exercisable."}],"balance_after":73036,"derivative":{"exercise_price":47.6,"expiration_date":"2026-08-07","underlying":"Common Stock","underlying_shares":36500},"source":{"system":"sec-edgar","filing":"0000914190-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000070/form4.xml","form_type":"4"}},{"id":807674,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-16T20:19:36.000Z","date":"2026-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":32088,"price":58.66,"value":1882282.08,"ownership":{"direct":true},"balance_after":53077,"source":{"system":"sec-edgar","filing":"0000914190-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000070/form4.xml","form_type":"4"}},{"id":807673,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-16T20:19:36.000Z","date":"2026-04-14","kind":"exercise","planned":false,"acquired":true,"shares":36500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":85165,"source":{"system":"sec-edgar","filing":"0000914190-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419026000070/form4.xml","form_type":"4"}},{"id":1007455,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-05T21:46:58.000Z","date":"2025-11-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2303,"price":62.57,"value":144098.71,"ownership":{"direct":true},"balance_after":48665,"source":{"system":"sec-edgar","filing":"0000914190-25-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419025000031/form4.xml","form_type":"4"}},{"id":1045377,"issuer":{"id":4691,"kind":"organization","name":"CONMED Corp","symbol":"CNMD"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true}}],"security":"Options To Purchase Common Stock","published_at":"2025-09-09T20:13:35.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":6227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The stock options were granted under the 2025 Long-Term Incentive Plan of CONMED Corporation (the \"Company) and generally vest 100% 1 year from the grant date."}],"balance_after":6227,"derivative":{"exercise_price":53.83,"exercise_date":"2026-09-08","expiration_date":"2035-09-08","underlying":"Common Stock","underlying_shares":6227},"source":{"system":"sec-edgar","filing":"0000816956-25-000040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816956/000081695625000040/form4.xml","form_type":"4"}},{"id":1045376,"issuer":{"id":4691,"kind":"organization","name":"CONMED Corp","symbol":"CNMD"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true}}],"security":"RSUs (Restricted Stock Units)","published_at":"2025-09-09T20:13:35.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the \"Company\") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The stock options were granted under the 2025 Long-Term Incentive Plan of CONMED Corporation (the \"Company) and generally vest 100% 1 year from the grant date."}],"balance_after":500,"derivative":{"exercise_price":0,"exercise_date":"2026-09-08","expiration_date":"2035-09-08","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0000816956-25-000040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816956/000081695625000040/form4.xml","form_type":"4"}},{"id":1063024,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-08-19T21:28:49.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":90441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028."}],"balance_after":90441,"derivative":{"exercise_price":53.6,"expiration_date":"2035-08-15","underlying":"Common Stock","underlying_shares":90441},"source":{"system":"sec-edgar","filing":"0001062993-25-014700","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325014700/form4.xml","form_type":"4"}},{"id":1063023,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-19T21:28:49.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":35354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028."}],"balance_after":35354,"derivative":{"underlying":"Common Stock","underlying_shares":35354},"source":{"system":"sec-edgar","filing":"0001062993-25-014700","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325014700/form4.xml","form_type":"4"}},{"id":1063022,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2025-08-19T21:28:49.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":70708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":70708,"derivative":{"underlying":"Common Stock","underlying_shares":70708},"source":{"system":"sec-edgar","filing":"0001062993-25-014700","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325014700/form4.xml","form_type":"4"}},{"id":1063021,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-19T21:28:49.000Z","date":"2025-08-15","kind":"exercise","planned":false,"acquired":false,"shares":8543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"8,543 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"8,543 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027."}],"balance_after":17087,"derivative":{"underlying":"Common Stock","underlying_shares":8543},"source":{"system":"sec-edgar","filing":"0001062993-25-014700","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325014700/form4.xml","form_type":"4"}},{"id":1063020,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-19T21:28:49.000Z","date":"2025-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4305,"price":53.6,"value":230748.0,"ownership":{"direct":true},"balance_after":50968,"source":{"system":"sec-edgar","filing":"0001062993-25-014700","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325014700/form4.xml","form_type":"4"}},{"id":1063019,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-19T21:28:49.000Z","date":"2025-08-15","kind":"exercise","planned":false,"acquired":true,"shares":8543,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":55273,"source":{"system":"sec-edgar","filing":"0001062993-25-014700","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325014700/form4.xml","form_type":"4"}},{"id":1082471,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-24T20:26:52.000Z","date":"2025-07-22","kind":"exercise","planned":false,"acquired":false,"shares":48176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":44.33,"expiration_date":"2025-08-08","underlying":"Common Stock","underlying_shares":48176},"source":{"system":"sec-edgar","filing":"0001062993-25-013134","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325013134/form4.xml","form_type":"4"}},{"id":1082470,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-24T20:26:52.000Z","date":"2025-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":43649,"price":53.12,"value":2318634.88,"ownership":{"direct":true},"balance_after":46730,"source":{"system":"sec-edgar","filing":"0001062993-25-013134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325013134/form4.xml","form_type":"4"}},{"id":1082469,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-24T20:26:52.000Z","date":"2025-07-22","kind":"exercise","planned":false,"acquired":true,"shares":48176,"price":44.33,"value":2135642.08,"ownership":{"direct":true},"balance_after":90379,"source":{"system":"sec-edgar","filing":"0001062993-25-013134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325013134/form4.xml","form_type":"4"}},{"id":1085988,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-17T21:04:37.000Z","date":"2025-07-15","kind":"exercise","planned":false,"acquired":false,"shares":36132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully exercisable."}],"balance_after":48176,"derivative":{"exercise_price":44.33,"expiration_date":"2025-08-08","underlying":"Common Stock","underlying_shares":36132},"source":{"system":"sec-edgar","filing":"0001062993-25-012967","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325012967/form4.xml","form_type":"4"}},{"id":1085987,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-17T21:04:37.000Z","date":"2025-07-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":32933,"price":51.42,"value":1693414.86,"ownership":{"direct":true},"balance_after":42203,"source":{"system":"sec-edgar","filing":"0001062993-25-012967","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325012967/form4.xml","form_type":"4"}},{"id":1085986,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-17T21:04:37.000Z","date":"2025-07-15","kind":"exercise","planned":false,"acquired":true,"shares":36132,"price":44.33,"value":1601731.56,"ownership":{"direct":true},"balance_after":75136,"source":{"system":"sec-edgar","filing":"0001062993-25-012967","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325012967/form4.xml","form_type":"4"}},{"id":1292291,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-29T21:35:39.000Z","date":"2025-01-27","kind":"exercise","planned":false,"acquired":false,"shares":13392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":37.7,"expiration_date":"2025-05-01","underlying":"Common Stock","underlying_shares":13392},"source":{"system":"sec-edgar","filing":"0001062993-25-001237","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325001237/form4.xml","form_type":"4"}},{"id":1292290,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-29T21:35:39.000Z","date":"2025-01-27","kind":"sale","planned":false,"acquired":false,"shares":1661,"price":77.953,"value":129479.933,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.69 to $78.08 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":39004,"source":{"system":"sec-edgar","filing":"0001062993-25-001237","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325001237/form4.xml","form_type":"4"}},{"id":1292289,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-29T21:35:39.000Z","date":"2025-01-27","kind":"sale","planned":false,"acquired":false,"shares":11731,"price":77.1915,"value":905533.4865,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.67 to $77.66 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":40665,"source":{"system":"sec-edgar","filing":"0001062993-25-001237","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325001237/form4.xml","form_type":"4"}},{"id":1292288,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-29T21:35:39.000Z","date":"2025-01-27","kind":"exercise","planned":false,"acquired":true,"shares":13392,"price":37.7,"value":504878.4,"ownership":{"direct":true},"balance_after":52396,"source":{"system":"sec-edgar","filing":"0001062993-25-001237","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299325001237/form4.xml","form_type":"4"}},{"id":1376432,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-05T21:47:31.000Z","date":"2024-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2430,"price":75.31,"value":183003.3,"ownership":{"direct":true},"balance_after":39004,"source":{"system":"sec-edgar","filing":"0001062993-24-018334","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324018334/form4.xml","form_type":"4"}},{"id":1418461,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-03T20:05:23.000Z","date":"2024-08-29","kind":"exercise","planned":false,"acquired":false,"shares":1492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully exercisable."}],"balance_after":115724,"derivative":{"exercise_price":66.97,"expiration_date":"2027-08-05","underlying":"Common Stock","underlying_shares":1492},"source":{"system":"sec-edgar","filing":"0001062993-24-015997","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324015997/form4.xml","form_type":"4"}},{"id":1418460,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-03T20:05:23.000Z","date":"2024-08-29","kind":"exercise","planned":false,"acquired":true,"shares":1492,"price":66.97,"value":99919.24,"ownership":{"direct":true},"balance_after":41434,"source":{"system":"sec-edgar","filing":"0001062993-24-015997","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324015997/form4.xml","form_type":"4"}},{"id":1430279,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-08-19T21:29:40.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":69061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028."}],"balance_after":69061,"derivative":{"exercise_price":74.91,"expiration_date":"2034-08-15","underlying":"Common Stock","underlying_shares":69061},"source":{"system":"sec-edgar","filing":"0001062993-24-015385","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324015385/form4.xml","form_type":"4"}},{"id":1430278,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-08-19T21:29:40.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":25630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"8,543 restricted stock units vest on each of  8/15/2025 and 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"8,543 restricted stock units vest on each of  8/15/2025 and 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027."}],"balance_after":25630,"derivative":{"underlying":"Common Stock","underlying_shares":25630},"source":{"system":"sec-edgar","filing":"0001062993-24-015385","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324015385/form4.xml","form_type":"4"}},{"id":1430277,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2024-08-19T21:29:40.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":51261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":51261,"derivative":{"underlying":"Common Stock","underlying_shares":51261},"source":{"system":"sec-edgar","filing":"0001062993-24-015385","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324015385/form4.xml","form_type":"4"}},{"id":1443630,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-02T20:17:04.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully exercisable."}],"balance_after":13392,"derivative":{"exercise_price":37.7,"expiration_date":"2025-05-01","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001062993-24-014366","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324014366/form4.xml","form_type":"4"}},{"id":1443629,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-02T20:17:04.000Z","date":"2024-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":9479,"price":81.97,"value":776993.63,"ownership":{"direct":true},"balance_after":39942,"source":{"system":"sec-edgar","filing":"0001062993-24-014366","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324014366/form4.xml","form_type":"4"}},{"id":1443628,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-02T20:17:04.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":true,"shares":14000,"price":37.7,"value":527800.0,"ownership":{"direct":true},"balance_after":49421,"source":{"system":"sec-edgar","filing":"0001062993-24-014366","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324014366/form4.xml","form_type":"4"}},{"id":1659977,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-02-05T23:33:36.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":51890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028."}],"balance_after":51890,"derivative":{"exercise_price":68.54,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":51890},"source":{"system":"sec-edgar","filing":"0001062993-24-002018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324002018/form4.xml","form_type":"4"}},{"id":1659976,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-02-05T23:33:36.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":25945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":25945,"derivative":{"exercise_price":68.54,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":25945},"source":{"system":"sec-edgar","filing":"0001062993-24-002018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324002018/form4.xml","form_type":"4"}},{"id":1659975,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-05T23:33:36.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":9423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":9423,"derivative":{"underlying":"Common Stock","underlying_shares":9423},"source":{"system":"sec-edgar","filing":"0001062993-24-002018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324002018/form4.xml","form_type":"4"}},{"id":1711664,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-14T23:13:26.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":23881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":23881,"derivative":{"exercise_price":84.61,"expiration_date":"2030-08-15","underlying":"Common Stock","underlying_shares":23881},"source":{"system":"sec-edgar","filing":"0001062993-23-022601","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323022601/form4a.xml","form_type":"4/A","original_submission_date":"2023-08-17"}},{"id":1711663,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Restricted Stock Units","published_at":"2023-12-14T23:13:26.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":8873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":8873,"derivative":{"underlying":"Common Stock","underlying_shares":8873},"source":{"system":"sec-edgar","filing":"0001062993-23-022601","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323022601/form4a.xml","form_type":"4/A","original_submission_date":"2023-08-17"}},{"id":1750689,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-11-03T22:34:53.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":38252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027."}],"balance_after":38252,"derivative":{"exercise_price":52.83,"expiration_date":"2030-11-01","underlying":"Common Stock","underlying_shares":38252},"source":{"system":"sec-edgar","filing":"0001062993-23-020118","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323020118/form4.xml","form_type":"4"}},{"id":1750688,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-11-03T22:34:53.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":14196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 14,196 shares of restricted stock for which risks of forfeiture lapse as to 4,732 shares on each of 11/1/2024, 11/1/2025 and 11/1/2026."}],"balance_after":35421,"source":{"system":"sec-edgar","filing":"0001062993-23-020118","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323020118/form4.xml","form_type":"4"}},{"id":1795771,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-28T20:19:15.000Z","date":"2023-08-24","kind":"exercise","planned":false,"acquired":false,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully exercisable."}],"balance_after":109536,"derivative":{"exercise_price":47.6,"expiration_date":"2026-08-07","underlying":"Common Stock","underlying_shares":2100},"source":{"system":"sec-edgar","filing":"0001062993-23-017156","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323017156/form4.xml","form_type":"4"}},{"id":1795770,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2023-08-28T20:19:15.000Z","date":"2023-08-24","kind":"exercise","planned":false,"acquired":true,"shares":2100,"price":47.6,"value":99960.0,"ownership":{"direct":true},"balance_after":21225,"source":{"system":"sec-edgar","filing":"0001062993-23-017156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323017156/form4.xml","form_type":"4"}},{"id":1804670,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-08-17T20:20:24.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":29391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026."}],"balance_after":29391,"derivative":{"exercise_price":84.61,"expiration_date":"2030-08-15","underlying":"Common Stock","underlying_shares":29391},"source":{"system":"sec-edgar","filing":"0001062993-23-016714","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323016714/form4.xml","form_type":"4"}},{"id":1804669,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-08-17T20:20:24.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":22043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":22043,"derivative":{"exercise_price":84.61,"expiration_date":"2030-08-15","underlying":"Common Stock","underlying_shares":22043},"source":{"system":"sec-edgar","filing":"0001062993-23-016714","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323016714/form4.xml","form_type":"4"}},{"id":1804668,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Restricted Stock Units","published_at":"2023-08-17T20:20:24.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":8191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":8191,"derivative":{"underlying":"Common Stock","underlying_shares":8191},"source":{"system":"sec-edgar","filing":"0001062993-23-016714","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323016714/form4.xml","form_type":"4"}},{"id":1813412,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Restricted Stock Units","published_at":"2023-08-08T21:28:37.000Z","date":"2023-08-05","kind":"exercise","planned":false,"acquired":false,"shares":8060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On 8/5/2023, the Board of Directors certified vesting of 8,060 performance RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On 8/5/2023, the Board of Directors certified vesting of 8,060 performance RSUs."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8060},"source":{"system":"sec-edgar","filing":"0001062993-23-016036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323016036/form4.xml","form_type":"4"}},{"id":1813411,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2023-08-08T21:28:37.000Z","date":"2023-08-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":4139,"price":82.17,"value":340101.63,"ownership":{"direct":true},"balance_after":19125,"source":{"system":"sec-edgar","filing":"0001062993-23-016036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323016036/form4.xml","form_type":"4"}},{"id":1813410,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2023-08-08T21:28:37.000Z","date":"2023-08-05","kind":"exercise","planned":false,"acquired":true,"shares":8060,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23264,"source":{"system":"sec-edgar","filing":"0001062993-23-016036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323016036/form4.xml","form_type":"4"}},{"id":2174380,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"officer":true,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-25T21:38:57.000Z","date":"2022-08-23","kind":"exercise","acquired":false,"shares":663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully exercisable."}],"balance_after":6848,"derivative":{"exercise_price":150.78,"expiration_date":"2025-05-01","underlying":"Common Stock","underlying_shares":663},"source":{"system":"sec-edgar","filing":"0001437749-22-021367","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922021367/rdgdoc.xml","form_type":"4"}},{"id":2174379,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"officer":true,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2022-08-25T21:38:57.000Z","date":"2022-08-23","kind":"exercise","acquired":true,"shares":663,"price":150.78,"value":99967.14,"ownership":{"direct":true},"balance_after":3801,"source":{"system":"sec-edgar","filing":"0001437749-22-021367","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922021367/rdgdoc.xml","form_type":"4"}},{"id":2182894,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRES. DIAGNOSTICS & GENOM"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-08-17T21:25:16.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":7235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to purchase 1,809 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 1,808 shares vest on 8/15/2025."}],"balance_after":7235,"derivative":{"exercise_price":378.08,"expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":7235},"source":{"system":"sec-edgar","filing":"0001415889-22-008784","document":"form4-08172022_020800.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922008784/form4-08172022_020800.xml","form_type":"4"}},{"id":2182893,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRES. DIAGNOSTICS & GENOM"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-08-17T21:25:16.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":5426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":5426,"derivative":{"exercise_price":378.08,"expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":5426},"source":{"system":"sec-edgar","filing":"0001415889-22-008784","document":"form4-08172022_020800.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922008784/form4-08172022_020800.xml","form_type":"4"}},{"id":2182892,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRES. DIAGNOSTICS & GENOM"}}],"security":"Restricted Stock Units","published_at":"2022-08-17T21:25:16.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":1746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":1746,"derivative":{"underlying":"Common Stock","underlying_shares":1746},"source":{"system":"sec-edgar","filing":"0001415889-22-008784","document":"form4-08172022_020800.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922008784/form4-08172022_020800.xml","form_type":"4"}},{"id":2191438,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"officer":true,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Restricted Stock Units","published_at":"2022-08-09T23:00:47.000Z","date":"2022-08-07","kind":"exercise","acquired":false,"shares":2363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On 8/7/2022, the Board of Directors certified vesting of 2,363 performance RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On 8/7/2022, the Board of Directors certified vesting of 2,363 performance RSUs."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2363},"source":{"system":"sec-edgar","filing":"0001437749-22-019667","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019667/rdgdoc.xml","form_type":"4"}},{"id":2191437,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"officer":true,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2022-08-09T23:00:47.000Z","date":"2022-08-07","kind":"tax_withholding","acquired":false,"shares":1214,"price":382.97,"value":464925.58,"ownership":{"direct":true},"balance_after":3138,"source":{"system":"sec-edgar","filing":"0001437749-22-019667","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019667/rdgdoc.xml","form_type":"4"}},{"id":2191436,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"officer":true,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2022-08-09T23:00:47.000Z","date":"2022-08-07","kind":"exercise","acquired":true,"shares":2363,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4352,"source":{"system":"sec-edgar","filing":"0001437749-22-019667","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019667/rdgdoc.xml","form_type":"4"}},{"id":2405213,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"officer":true,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-10T21:31:14.000Z","date":"2022-02-08","kind":"exercise","acquired":false,"shares":1989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 2,500 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022."}],"balance_after":7511,"derivative":{"exercise_price":150.78,"expiration_date":"2025-05-01","underlying":"Common Stock","underlying_shares":1989},"source":{"system":"sec-edgar","filing":"0001437749-22-003021","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922003021/rdgdoc.xml","form_type":"4"}},{"id":2405212,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"officer":true,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2022-02-10T21:31:14.000Z","date":"2022-02-08","kind":"exercise","acquired":true,"shares":1989,"price":150.78,"value":299901.42,"ownership":{"direct":true},"balance_after":1989,"source":{"system":"sec-edgar","filing":"0001437749-22-003021","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922003021/rdgdoc.xml","form_type":"4"}},{"id":2499564,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"officer":true,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-24T01:02:07.000Z","date":"2021-11-19","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to purchase 663 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022."}],"balance_after":2152,"derivative":{"exercise_price":150.78,"expiration_date":"2025-05-01","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001437749-21-027339","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774921027339/rdgdoc.xml","form_type":"4"}},{"id":2499563,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"officer":true,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2021-11-24T01:02:07.000Z","date":"2021-11-19","kind":"sale","acquired":false,"shares":400,"price":505.7825,"value":202313.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $505.62 to $506.17, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-21-027339","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774921027339/rdgdoc.xml","form_type":"4"}},{"id":2499562,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"officer":true,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2021-11-24T01:02:07.000Z","date":"2021-11-19","kind":"sale","acquired":false,"shares":100,"price":503.76,"value":50376.0,"ownership":{"direct":true},"balance_after":400,"source":{"system":"sec-edgar","filing":"0001437749-21-027339","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774921027339/rdgdoc.xml","form_type":"4"}},{"id":2499561,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"officer":true,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2021-11-24T01:02:07.000Z","date":"2021-11-19","kind":"exercise","acquired":true,"shares":500,"price":150.78,"value":75390.0,"ownership":{"direct":true},"balance_after":500,"source":{"system":"sec-edgar","filing":"0001437749-21-027339","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774921027339/rdgdoc.xml","form_type":"4"}},{"id":2560435,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2021-09-24T20:30:53.000Z","date":"2021-09-22","kind":"sale","acquired":false,"shares":822,"price":529.04,"value":434870.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000914190-21-000374","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000374/edgar.xml","form_type":"4"}},{"id":2609373,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-10T22:21:26.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":6486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Options to purchase 1,622 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 1,621 shares vest on each of 8/6/2024 and 8/6/2025."}],"balance_after":6486,"derivative":{"exercise_price":481.82,"expiration_date":"2028-08-06","underlying":"Common Stock","underlying_shares":6486},"source":{"system":"sec-edgar","filing":"0000914190-21-000215","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000215/edgar.xml","form_type":"4"}},{"id":2609372,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-10T22:21:26.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":4864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":4864,"derivative":{"exercise_price":481.82,"expiration_date":"2028-08-06","underlying":"Common Stock","underlying_shares":4864},"source":{"system":"sec-edgar","filing":"0000914190-21-000215","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000215/edgar.xml","form_type":"4"}},{"id":2609371,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Restricted Stock Units","published_at":"2021-08-10T22:21:26.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":1245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":1245,"derivative":{"underlying":"Common Stock","underlying_shares":1245},"source":{"system":"sec-edgar","filing":"0000914190-21-000215","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000215/edgar.xml","form_type":"4"}},{"id":2609370,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Restricted Stock Units","published_at":"2021-08-10T22:21:26.000Z","date":"2021-08-08","kind":"exercise","acquired":false,"shares":1691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vested in full on 8/8/2021 upon the certification of achievement of performance goals."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Vested in full on 8/8/2021 upon the certification of achievement of performance goals."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1691},"source":{"system":"sec-edgar","filing":"0000914190-21-000215","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000215/edgar.xml","form_type":"4"}},{"id":2609369,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2021-08-10T22:21:26.000Z","date":"2021-08-08","kind":"tax_withholding","acquired":false,"shares":869,"price":481.82,"value":418701.58,"ownership":{"direct":true},"balance_after":822,"source":{"system":"sec-edgar","filing":"0000914190-21-000215","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000215/edgar.xml","form_type":"4"}},{"id":2609368,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2021-08-10T22:21:26.000Z","date":"2021-08-08","kind":"exercise","acquired":true,"shares":1691,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1691,"source":{"system":"sec-edgar","filing":"0000914190-21-000215","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000215/edgar.xml","form_type":"4"}},{"id":2672865,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2021-06-11T20:59:49.000Z","date":"2021-06-09","kind":"sale","acquired":false,"shares":811,"price":433,"value":351163.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000914190-21-000183","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000183/edgar.xml","form_type":"4"}},{"id":2694285,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2021-05-27T20:26:50.000Z","date":"2021-05-25","kind":"sale","acquired":false,"shares":845,"price":424,"value":358280.0,"ownership":{"direct":true},"balance_after":811,"source":{"system":"sec-edgar","filing":"0000914190-21-000166","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000166/edgar.xml","form_type":"4"}},{"id":2731514,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Restricted Stock Units","published_at":"2021-05-04T20:54:22.000Z","date":"2021-05-01","kind":"exercise","acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1,667 restricted stock units vest on 5/1/2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1,667 restricted stock units vest on 5/1/2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0000914190-21-000134","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000134/edgar.xml","form_type":"4"}},{"id":2731513,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2021-05-04T20:54:22.000Z","date":"2021-05-01","kind":"tax_withholding","acquired":false,"shares":856,"price":427.49,"value":365931.44,"ownership":{"direct":true},"balance_after":1656,"source":{"system":"sec-edgar","filing":"0000914190-21-000134","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000134/edgar.xml","form_type":"4"}},{"id":2731512,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2021-05-04T20:54:22.000Z","date":"2021-05-01","kind":"exercise","acquired":true,"shares":1667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."}],"balance_after":2512,"source":{"system":"sec-edgar","filing":"0000914190-21-000134","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000134/edgar.xml","form_type":"4"}},{"id":2873108,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Common Stock","published_at":"2021-02-09T23:31:01.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":823,"price":388.45,"value":319694.35,"ownership":{"direct":true},"balance_after":845,"source":{"system":"sec-edgar","filing":"0000914190-21-000039","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000039/edgar.xml","form_type":"4"}},{"id":3065285,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-07T22:58:18.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":8325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021"}],"balance_after":8325,"derivative":{"exercise_price":267.87,"expiration_date":"2027-08-05","underlying":"Common Stock","underlying_shares":8325},"source":{"system":"sec-edgar","filing":"0000914190-20-000251","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000251/edgar.xml","form_type":"4"}},{"id":3065284,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-07T22:58:18.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":8325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023."}],"balance_after":8325,"derivative":{"exercise_price":267.87,"expiration_date":"2027-08-05","underlying":"Common Stock","underlying_shares":8325},"source":{"system":"sec-edgar","filing":"0000914190-20-000251","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000251/edgar.xml","form_type":"4"}},{"id":3065283,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21871,"kind":"person","name":"Kelderman Kim","position":1,"cik":"0001739054","reported_name":"Kelderman Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Diagnostics & Genom"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-07T22:58:18.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":11988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024."}],"balance_after":11988,"derivative":{"exercise_price":267.87,"expiration_date":"2027-08-05","underlying":"Common Stock","underlying_shares":11988},"source":{"system":"sec-edgar","filing":"0000914190-20-000251","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000251/edgar.xml","form_type":"4"}}],"next_cursor":"2020-08-07T22:58:18.000000Z,3065283"}